Chapter 1: Overview of Real-World Data

References

  1. U.S. Food and Drug Administration. Framework for FDA’s Real-World Evidence Program. Published online January 4, 2022. Accessed January 4, 2022. https://www.fda.gov/media/120060/download
  2. U.S. Food and Drug Administration. Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products. Published October 27, 2021. Accessed November 30, 2021. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/real-world-data-assessing-…
  3. Curtis LH, Weiner MG, Boudreau DM, et al. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012;21 Suppl 1:23-31. doi:10.1002/pds.2336
  4. Richard Platt, Pamela Tenaerts, Patrick Archdeacon, et al. Developing Approaches to Conducting Randomized Trials Using the Mini-Sentinel Distributed Database. Published online February 28, 2014. Accessed February 17, 2017. https://www.sentinelinitiative.org/sites/default/files/Methods/Mini-Sentinel_Methods_CTTI_Developin…
  5. Platt R, Brown JS, Robb M, et al. The FDA Sentinel Initiative — An Evolving National Resource. N Engl J Med. 2018;379(22):2091-2093. doi:10.1056/NEJMp1809643
  6. Qualls LG, Phillips TA, Hammill BG, et al. Evaluating Foundational Data Quality in the National Patient-Centered Clinical Research Network (PCORnet®). eGEMs. 2018;6(1):3. doi:10.5334/egems.199
  7. Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. Journal of the American Medical Informatics Association. 2014;21(4):578-582. doi:10.1136/amiajnl-2014-002747
  8. Califf RM. The Patient-Centered Outcomes Research Network: a national infrastructure for comparative effectiveness research. N C Med J. 2014;75(3):204-210. doi:10.18043/ncm.75.3.204
  9. May T. How America’s Health Data Infrastructure is Being Used to Fight COVID-19. Datavant. Accessed January 4, 2022. https://datavant.com/resources/blog/how-americas-health-data-infrastructure-is-being-used-to-fight-…
  10. Miksad RA, Abernethy AP. Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality. Clin Pharmacol Ther. 2018;103(2):202-205. doi:10.1002/cpt.946
  11. Marsolo K, Richesson R, Hammond WE. Rethinking Clinical Trials. Acquiring Real-Word Data. NIH Health Care Systems Research Collaboratory https://rethinkingclinicaltrials.org/chapters/conduct/acquiring-real-world-data/common-real-world-d…
  12. Tang PC, Ash JS, Bates DW, Overhage JM, Sands DZ. Personal Health Records: Definitions, Benefits, and Strategies for Overcoming Barriers to Adoption. Journal of the American Medical Informatics Association. 2006;13(2):121-126. doi:10.1197/jamia.M2025
  13. U.S. Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures:  Use in Medical Product Development  to Support Labeling Claims. Published online December 2009. Accessed September 25, 2013. http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf
  14. Chen M, Tan X, Padman R. Social determinants of health in electronic health records and their impact on analysis and risk prediction: A systematic review. Journal of the American Medical Informatics Association. 2020;27(11):1764-1773. doi:10.1093/jamia/ocaa143
  15. Eisenstein EL, Curtis LH, Prather K, et al. Using Death as an Endpoint. In: The Living Textbook. NIH Collaboratory; 2017. doi:10.28929/118
  16. Pratt NL, Mack CD, Meyer AM, et al. Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting. Pharmacoepidemiol Drug Saf. 2020;29(1):9-17. doi:10.1002/pds.4924
  17. Rivera DR, Gokhale MN, Reynolds MW, et al. Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility. Pharmacoepidemiol Drug Saf. 2020;29(1):18-29. doi:10.1002/pds.4918
  18. Daniel G, Silcox C, Bryan J. Characterizing RWD Quality and Relevancy for Regulatory Purposes. Accessed January 4, 2022. https://healthpolicy.duke.edu/sites/default/files/2020-03/characterizing_rwd.pdf
  19. Gatto NM, Campbell UB, Rubinstein E, et al. The Structured Process to Identify Fit‐For‐Purpose Data: A Data Feasibility Assessment Framework. Clin Pharma and Therapeutics. 2022;111(1):122-134. doi:10.1002/cpt.2466
  20. Federal Information Security Modernization Act | CISA. Accessed January 27, 2022. https://www.cisa.gov/federal-information-security-modernization-act
  21. Nifakos S, Chandramouli K, Nikolaou CK, et al. Influence of Human Factors on Cyber Security within Healthcare Organisations: A Systematic Review. Sensors. 2021;21(15):5119. doi:10.3390/s21155119